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Abstract 
Purpose: To explore the anti-hepatoma effect of Gan-Ai-Xiao Decoction (GAXD), a folk remedy. 
Methods: High performance liquid chromatography (HPLC) was used to identify the major chemical 
components of GAXD ethanol extract (EE). The cytotoxic effect of GAXD EE against HepG2 cells was 
measured by methyl thiazolyl tetrazolium (MTT) assay. Flow cytometry and Western blot were used to 
study the effect of GAXD EE on apoptosis and apoptotic proteins (Bcl-2, Bax and caspase-3) in HepG2 
cells. Xenograft assay was used to evaluate the anti-hepatoma effect of GAXD EE in vivo. 
Results: Four components were identified in GAXD EE by HPLC. The results of MTT and flow 
cytometry assays indicated that GAXD EE significantly reduced HepG2 cells viability (p < 0.05) and 
induced its apoptosis. The results of Western blot assay suggested that GAXD EE down-regulated the 
expression of anti-apoptotic protein (Bcl-2) and up-regulated the expression of pro-apoptotic proteins 
(Bax and caspase-3) in HepG2 cells. Furthermore, the results of xenograft assay showed that GAXD 
EE significantly inhibited the growth of HepG2 cells-induced tumor (p < 0.05) without any effect on the 
body weight of nude mice. 
Conclusion: GAXD has anti-hepatoma activity, and the mechanism is associated with apoptosis. 
Keywords: Gan-Ai-Xiao Decoction, Anti-hepatoma, Flow cytometry, Western blot, Xenograft, HepG2 
cells, Apoptosis 
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The liver plays an important role in metabolism 
and has many functions in human life, such as 
detoxification, glycogen storage and plasma 
protein synthesis. However, patients with liver 
cancer are facing afunction of the liver. 
Nowadays, the people’s lifestyles such as 
obesity [1], smoking [2] and alcohol drinking [3] 
enhance the incidence of hepatoma. Hepatoma 
is the second leading cause of cancer mortality 
worldwide [4] and a number of therapies have 
been used to decrease the mortality of patients 
with hepatoma, such as surgical treatment [5], 
interventional therapy [6-8], biotherapy [9], 
radiotherapy [10,11], chemotherapy [12], 
adjunctive traditional Chinese medicine (TCM) 
therapy [13,14]. According to clinical observation, 
adjunctive TCM therapy has unique advantages, 
such as stabilizing patient condition, low toxicity 
and side effect, improving clinical symptoms, 
prolonging patients’ survival time and low cost. 
 
GAXD, a folk medicine, is composed of Stigma 
Maydis, Kummerowia Herbal, Gleditsiae Spina, 
Astragali Radix, Poria, Glycyrrhizae Radix (Table 
1). GAXD has been used to cure hepatoma with 
a long history in Southwestern China, such as 
Tianshui, Baoji and Bazhong, but there were not 
any study reports about its anti-hepatoma effect. 
Yuan et al 
Trop J Pharm Res, July 2015; 14(7): 1250  
 
In this work, we identified the major chemical 
components and studied anti-hepatoma effect of 
GAXD by HPLC, MTT, flow cytometry, western 






Stigma Maydis, Kummerowia Herbal, Gleditsiae 
Spina, Astragali Radix, Poria and Glycyrrhizae 
Radix were collected from Sichuan, Henan, 
Shanxi and Jiangxi in 2010. Their original plants 
were identified by Department of Pharmacy, 
People Hospital of Cangzhou city, Cangzhou 
Hebei. All air-dried plant materials were used to 
form GAXD. A series of voucher specimen 
(2010022-2010027/PHCZCHB) were deposited 
in Department of Pharmacy, People Hospital of 
Cangzhou city, Cangzhou Hebei for future 
reference. 
 
Chemicals and reagents 
 
HPLC grade methanol was purchased from 
Fisher (Fisher Scientific, USA). Analytical grade 
DMSO, phosphoric acid and ethanol were 
purchased from Sinopharm Chemical Reagent 
Co. (Shanghai, China). Ultra-pure water was 
obtained from Milli-Q Advantage A10 (Millipore 
Crop., MA, USA). Isoorientin, quercetin, luteolin 
and apigenin were purchased from Shanghai 
shifeng biological technology Co. ltd (Shanghai, 
China) and the National Institute for the Control 
of Pharmaceutical and Biological Products 
(Beijing, China). Bcl-2, Bax and caspase-3 
monoclonal antibodies were obtained from 
Abcam Co. (Hong Kong, China). Goat anti-
rabbit/HRP was obtained from Shanghai Hao 




Nude mice (5 - 6 weeks old) were purchased 
from the SLRC Laboratory Animal Company 
(Shanghai, China). All animal treatments were 
strictly in accordance with the international 
ethical guidelines and the National Institutes of 
Health Guide concerning the Care and Use of 
Laboratory Animals [15]. Experiments were 
carried out with the approval of the Animal 
Experimentation Ethics Committee of People 
Hospital of Cangzhou city, Cangzhou Hebei. 
 
Preparation of GAXD ethanol extract 
 
All crude drugs of GAXD were powdered 
together according to the composition shown in 
Table 1. The powder was extracted 3 times (6 h 
× 3) with 75 % ethanol at room temperature. 
Evaporation of the 75 % ethanol under reduced 
pressure provided the GAXD ethanol extract 
(EE) (13.6 g/100 g), which was diluted with 0.5 % 
DMSO to obtain the required concentrations for 
the various tests. 
 
Identification of major chemical components 
of GAXD EE 
 
The GAXD EE was dissolved in methanol to get 
appropriate concentrations for HPLC analysis. 
The identification of chemical components of 
GAXD EE was performed with Agilent 
Technologies 1100 system (Agilent Crop., MA, 
USA). The chromatography was carried out on 
an Eclipse XDB-C18 column (4.6 mm × 250 mm, 
5 μm). The mobile phase was composed of 
methanol (solvent A) and 0.2 % phosphoric acid 
(solvent B): 0 - 20 min (20 – 45 %, A), 20 - 30 
min (45 – 70 %, A), 30 - 38 min (70 – 100 %, A). 
The column temperature was 30 °C. The 
injection volume was 15 μL. The flow rate was 1 




Human hepatoma cell line (HepG2) was obtained 
from American Type Culture Collection 
(Manassas, Virginia, VA, USA). The cells were 
cultured in RPMI-1640 medium supplemented 
with antibiotics (100 μg/mL streptomycin and 100 
U/mL penicillin) and 10 % fetal bovine serum. 
The cells were cultured with a humid atmosphere 
of 5 % CO2 and 95 % air at 37 °C. Then the 
logarithmic-growth phase cells were used to 
evaluate the anti-hepatoma effect of GAXD EE.  
 
 
Table 1: Composition of Gan-Ai-Xiao Decoction (GAXD) 
 
Plant Family Original plant Weight (g) 
Stigma Maydis Poaceae Zea mays L. 30 
Kummerowia Herbal Leguminosae Kummerowia striata (Thunb.) Schindl 30 
Gleditsiae Spina Leguminosae Gleditsia sinensis Lam 15 
Astragali Radix Leguminosae Astragalus membranaceus (Fisch.) Bunge. 15 
Poria Polyporaceae Wolfiporia cocos (Schw.) Ryv.&Gibn 10 
Glycyrrhizae Radix Leguminosae Glycyrrhiza uralensis Fisch 5 
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HepG2 cells (1 × 104/0.2 mL) were seeded on 
96-well plates and incubated for 24 h. Then cells 
were separately treated with GAXD EE (20, 40 
and 80 μg/mL) and 0.05 % DMSO (control) for 
48 h. Subsequently, MTT assay was performed 
using a standard protocol and the absorbance of 
both control (Ac) and treated (At) samples was 
measured at 490 nm in a microplate reader 
(Multiskan FC, Thermo, MA, USA). Inhibition was 
calculated as in Eq 1 [16]: 
 
Inhibition (%) = {(Ac – At)/Ac}100 ………… (1) 
 
Apoptosis assay by flow cytometry 
 
HepG2 cells, separately treated with GAXD EE 
(20, 40 and 80 μg/mL) and 0.05 % DMSO 
(control) for 48 h, were harvested by 
centrifugation. Then the cells were washed with 
cold phosphate buffered saline (PBS) twice, 
stained with Annexin V-FITC and propidium 
iodide (PI) according to the manufacturer’s 
instructions. Subsequently, the stained cells were 
analyzed by flow cytometry on a FACScalibur 
flow cytometer (BD Biosciences, San Jose, CA, 
USA). 
 
Western blot analysis 
 
After treatment with GAXD EE (20, 40 and 80 
μg/mL) and 0.05 % DMSO (control) for 48 h, 
HepG2 cells were harvested and their total 
proteins were extracted. The concentration of 
total proteins was determined by the Enhanced 
BCA Protein Assay kit (Beyotime, Haimen, 
Chian). About 40 μg total proteins were 
separated by SDS/PAGE and blotted on PVDF 
membrane. Then PVDF membranes with target 
protein were probed with anti-Bcl-2, Bax and 
caspase-3 rabbit polyclonal IgG and 
subsequently with goat anti-rabbit/HRP, and 
detected by chemiluminescence. Antibody 





Nude mice (5 - 6 weeks old) were randomly 
divided into two groups, control and treatment 
groups (n = 8). HepG2 cells (2 × 106 cells per 
nude mouse) were injected in the right flank of 
mice subcutaneously. When the HepG2-induced 
tumors grew to about 2 - 3 mm in diameter, the 
control and treatment groups were separately 
treated with 0.05 % DMSO and GAXD EE (100 
mg/kg) for 15 days by gavage. The tumor sizes 
(width and length) and body weight of nude mice 
were measured in 5th, 10th and 15th days by a 
vernier caliper. The tumor volumes were 
calculated as in Eq 2 [17]. At last, all animals 
were sacrificed by injecting chloral hydrate. 
 




All data are presented as mean ± standard 
deviation (SD). The difference between groups 
was analyzed by two-tailed Student’s t-test in 
SPSS 21.0. When p-value was less than 0.05, 





Major chemical components of GAXD EE 
 
As shown in Figure 1, four components, 
isoorientin, quercetin, luteolin and apigenin, were 
identified in GAXD EE according to standard 
substance by HPLC. 
 
Cytotoxic effects of GAXD EE on HepG2 cells 
 
The results of MTT assay indicated that GAXD 
EE (20, 40 and 80 μg/mL) significantly (p < 0.05) 
reduced the HepG2 cells viability in a dose-
dependent manner, compared with control. The 
results are shown in Figure 2. 
 
Effects of GAXD EE on apoptosis of HepG2 
cells 
 
As depicted in Figure 3, the results of flow 
cytometry assay indicated that GAXD EE (20, 40 
and 80 μg/mL) induced the apoptosis of HepG2 
cells in a dose-dependent manner. 
 
Effects of GAXD EE on apoptotic proteins of 
HepG2 cells 
 
The results of western blot assay suggested that 
GAXD EE (20, 40 and 80 μg/mL) obviously 
down-regulated the expression of anti-apoptotic 
protein (Bcl-2) and up-regulated the expression 
of pro-apoptotic proteins (Bax and caspase-3) in 
a dose-dependent manner. The results are 
shown in Figure 4. 
 
Anti-tumor effects of GAXD EE on HepG2 
cells-induced tumor 
 
Xenograft assay of nude mice was used to 
evaluate the anti-tumor effect of GAXD EE on 
HepG2 cells-induced tumor in vivo. Tumor 
volume and body weight of nude mice were used 
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to evaluate the anti-tumor effect. As depicted in 
Figure 5, GAXD EE significantly (p < 0.05) 
inhibited the growth of HepG2 cells-induced 
tumor without any effect on the body weight of 
the mice, compared with control. 
 
 




Figure 2: Cytotoxic effect of GAXD ethanol extract on 
HepG2 cells. HepG2 cells were treated with 0.05% 
DMSO (control) and GAXD ethanol extract (20, 40 and 
80 μg/mL) for 48 h; * p < 0.05, ** p < 0.01, *** p < 




In this work, we research the major chemical 
components and anti-hepatoma effect of GAXD 
by HPLC, MTT, flow cytometry, Western blot and 
xenograft assays for the first time. The study on 
identification of major chemical components 
shows that what the active components are in 
GAXD. 
 
MTT assay, a common method, is used to 
evaluate the cytotoxic effect of drug against 
cultured cells in vitro by determining cells viability 
[18,19]. Viable cells induce MTT to generate the 
purple-blue formazan precipitate, but dead cells 
lose this function. The absorbance of formazan 
dissolved in DMSO is used to analyze the 
cytotoxic effect of drugs on cells. The result of 
MTT assay indicated that GAXD EE had 
significant cytotoxic activity against HepG2 cells 
(Figure 2). 
 
Flow cytometry assay [20,21] was used to study 
whether the cytotoxic activity of GAXD EE 
against HepG2 cells was associated with 
apoptosis. The cells in early apoptosis were 
stained with Annexin V-FITC and cells in late 
apoptosis were stained with Annexin V-FITC and 
PI. Subsequently, cells were analyzed by flow 
cytometry and different kinds of cells including 
dead cells, viable cells, cells in early apoptosis 
and cells in late apoptosis were counted 
respectively. According to the results of counting 
in flow cytometry, we can easily analyze whether 
drugs induce apoptosis of cells. The results of 
flow cytometry suggested that the cytotoxic 
activity of GAXD EE against HepG2 cells was 
associated with apoptosis (Figure 3). 
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Figure 3: Effects of GAXD ethanol extract on 
apoptosis of HepG2 cells. HepG2 cells were treated 
with 0.05% DMSO (control) and GAXD ethanol extract 
(20, 40 and 80 μg/mL) for 48 h; A, B, C, D stood for 




Figure 4: Effect of GAXD ethanol extract on apoptotic 
proteins (Bcl-2, Bax and caspase-3) of HepG2 cells. 
HepG2 cells were separately treated with 0.05% 
DMSO (control) and GAXD ethanol extract (20, 40 and 




Figure 5: Anti-tumor effect of GAXD ethanol extract on 
HepG2 cells-induced tumor. Nude mice were treated 
with 0.05% DMSO (control) and GAXD ethanol extract 
(100 mg/kg) by gavage; * p < 0.05, ** p < 0.01, 
compared with control. 
 
The results of MTT and flow cytometry assays 
indicated that GAXD indeed have anti-hepatoma 
activity, associated with apoptosis. Western blot 
assay was used to study the effects of GAXD on 
apoptotic proteins, which were immediately 
related to apoptosis of cells. The apoptotic 
proteins were a research hotspot in the aspect of 
anti-tumor mechanism [22,23]. Bcl-2 protein 
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inhibits apoptosis of tumor cells, and Bax and 
caspase-3 proteins induce apoptosis of tumor 
cells [24]. As depicted in Figure 4, GAXD EE 
down-regulated the expression of anti-apoptotic 
protein (Bcl-2), and increased the expression of 
pro-apoptotic proteins (Bax and caspase-3). 
Namely, the anti-hepatoma mechanisms of 
GAXD were associated with apoptosis. 
 
Finally, the xenograft assay was used to verify 
the anti-tumor effect of GAXD in vivo. The results 
of xenograft assay indicated that GAXD EE 
significantly inhibited the growth of HepG2 cells-
induced tumor without any effect on the body 




GAXD shows anti-hepatoma activity in vitro and 
in vivo by inducing the apoptosis of HepG2 cells, 
associated with down-regulating the expression 
of anti-apoptotic protein (Bcl-2) and increasing 
the expression of pro-apoptotic proteins (Bax and 
caspase-3). Additionally, this work provides the 
evidences to support that GAXD is used to cure 
hepatoma. However, further studies to elucidate 
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